Adaptimmune Therapeutics PLC (ADAP)
1.38
+0.09
(+6.98%)
USD |
NASDAQ |
Jul 26, 16:00
1.42
+0.04
(+2.90%)
After-Hours: 20:00
Adaptimmune Therapeutics Price to Book Value: 14.47 for July 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 13.53 |
| July 24, 2024 | 12.90 |
| July 23, 2024 | 12.90 |
| July 22, 2024 | 12.69 |
| July 19, 2024 | 12.27 |
| July 18, 2024 | 12.37 |
| July 17, 2024 | 13.21 |
| July 16, 2024 | 13.32 |
| July 15, 2024 | 13.05 |
| July 12, 2024 | 13.42 |
| July 11, 2024 | 13.00 |
| July 10, 2024 | 12.48 |
| July 09, 2024 | 12.58 |
| July 08, 2024 | 12.16 |
| July 05, 2024 | 12.79 |
| July 03, 2024 | 10.69 |
| July 02, 2024 | 11.01 |
| July 01, 2024 | 11.01 |
| June 28, 2024 | 10.22 |
| June 27, 2024 | 10.28 |
| June 26, 2024 | 8.718 |
| June 25, 2024 | 9.079 |
| June 24, 2024 | 9.233 |
| June 21, 2024 | 9.331 |
| June 20, 2024 | 9.151 |
| Date | Value |
|---|---|
| June 18, 2024 | 9.226 |
| June 17, 2024 | 9.824 |
| June 14, 2024 | 10.59 |
| June 13, 2024 | 10.90 |
| June 12, 2024 | 10.90 |
| June 11, 2024 | 10.90 |
| June 10, 2024 | 10.90 |
| June 07, 2024 | 10.69 |
| June 06, 2024 | 10.80 |
| June 05, 2024 | 11.11 |
| June 04, 2024 | 10.59 |
| June 03, 2024 | 11.22 |
| May 31, 2024 | 11.85 |
| May 30, 2024 | 10.59 |
| May 29, 2024 | 10.59 |
| May 28, 2024 | 10.90 |
| May 24, 2024 | 11.01 |
| May 23, 2024 | 10.59 |
| May 22, 2024 | 11.01 |
| May 21, 2024 | 11.32 |
| May 20, 2024 | 11.53 |
| May 17, 2024 | 11.64 |
| May 16, 2024 | 12.58 |
| May 15, 2024 | 13.00 |
| May 14, 2024 | 12.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5163
Minimum
Nov 15 2019
15.41
Maximum
Apr 01 2024
3.239
Average
2.411
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | 1.806 |
| NuCana PLC | 0.6473 |
| Mereo BioPharma Group PLC | 14.82 |
| Autolus Therapeutics PLC | 2.139 |
| TC BioPharm (Holdings) PLC | 3.263 |
Price to Book Value Related Metrics
| PS Ratio | 16.54 |
| Price | 1.38 |
| Earnings Yield | -47.83% |
| Market Cap | 352.68M |